XFRA ISIN CHANGE

Realtime	Geld	Brief	Zeit
	19,720	20,100	11:49
	19,710	20,100	11:33

Realtime

Geld

Brief

Zeit

19,720

20,100

11:49

19,710

20,100

11:33

XFRA ISIN CHANGE

Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
CA80914P1018 Scope Carbon Corp. 04.04.2024 CA8091441086 Scope AI Corp. 05.04.2024 Tausch 1:1
NO0012450008 Ensurge Micropower ASA 04.04.2024 NO0013186460 Ensurge Micropower ASA 05.04.2024 Tausch 5:1
AU000000MXC6 Argent Biopharma Ltd. 04.04.2024 AU0000326647 Argent Biopharma Ltd. 05.04.2024 Tausch 1:1
US3765351008 Gladstone Capital Corp. 04.04.2024 US3765358789 Gladstone Capital Corp. 05.04.2024 Tausch 2:1
US8162121045 Cartesian Therapeutics Inc. 04.04.2024 US8162123025 Cartesian Therapeutics Inc. 05.04.2024 Tausch 30:1

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!

In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.

Hier klicken

Zeit	Aktuelle Nachrichten
Di	Argent Biopharma Ltd - PDMR Notification
Di	Argent Biopharma Ltd - March 2024 Quarter Activity Report
Di	ARGENT BIOPHARMA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report
26.04.	ARGENT BIOPHARMA LIMITED: Notification regarding unquoted securities - RGT
15.04.	ARGENT BIOPHARMA LIMITED: Notification of cessation of securities - RGT

Zeit

Aktuelle Nachrichten

Argent Biopharma Ltd - PDMR Notification

Argent Biopharma Ltd - March 2024 Quarter Activity Report

ARGENT BIOPHARMA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report

26.04.

ARGENT BIOPHARMA LIMITED: Notification regarding unquoted securities - RGT

15.04.

ARGENT BIOPHARMA LIMITED: Notification of cessation of securities - RGT

Zeit	Aktuelle Nachrichten
22.04.	Cartesian Therapeutics, Inc. - 8-K, Current Report
15.04.	Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare movers
10.04.	Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
09.04.	Cartesian Therapeutics, Inc. - 8-K, Current Report
05.04.	XFRA 1S70: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARTESIAN THERAP.... ► Artikel lesen

Zeit

Aktuelle Nachrichten

22.04.

Cartesian Therapeutics, Inc. - 8-K, Current Report

15.04.

Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare movers

10.04.

Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy

09.04.

Cartesian Therapeutics, Inc. - 8-K, Current Report

05.04.

XFRA 1S70: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARTESIAN THERAP....
► Artikel lesen

Zeit	Aktuelle Nachrichten
25.04.	Ensurge Micropower ASA - Annual Report and Financial Statements 2023	The Board of Directors of Ensurge Micropower ASA ("Ensurge") approved the annual report and the annual financial statements for 2023 on 24 April 2024. The financial statements are consistent with... ► Artikel lesen
24.04.	Ensurge Micropower ASA - Grant of Incentive Subscription Rights
23.04.	Ensurge Micropower ASA - Notice of Annual General Meeting 14 May 2024
22.04.	Ensurge Micropower ASA: Ensurge Delivers First Shipment of Solid-State Lithium Microbatteries to Leading Consumer Electronics Company	Oslo, April 22, 2023 -- Ensurge Micropower (OSE: ENSU, and OTCQB: ENMPY) ("Ensurge" or the "Company"), today announced it has completed its first shipment of the world's first fully functional multi-layer... ► Artikel lesen
10.04.	Ensurge Micropower ASA - Registration of Share Capital Increase

Zeit

Aktuelle Nachrichten

25.04.

Ensurge Micropower ASA - Annual Report and Financial Statements 2023

The Board of Directors of Ensurge Micropower ASA ("Ensurge") approved the annual report and the annual financial statements for 2023 on 24 April 2024. The financial statements are consistent with...
► Artikel lesen

24.04.

Ensurge Micropower ASA - Grant of Incentive Subscription Rights

23.04.

Ensurge Micropower ASA - Notice of Annual General Meeting 14 May 2024

22.04.

Ensurge Micropower ASA: Ensurge Delivers First Shipment of Solid-State Lithium Microbatteries to Leading Consumer Electronics Company

Oslo, April 22, 2023 -- Ensurge Micropower (OSE: ENSU, and OTCQB: ENMPY) ("Ensurge" or the "Company"), today announced it has completed its first shipment of the world's first fully functional multi-layer...
► Artikel lesen

10.04.

Ensurge Micropower ASA - Registration of Share Capital Increase

Zeit	Aktuelle Nachrichten
Do	Earnings call: Gladstone Capital reports Q2 results, maintains dividend growth
Do	Gladstone Capital declares $0.165 dividend
Mi	Gladstone Capital Corporation Reports Financial Results for Its Second Quarter Ended March 31, 2024	MCLEAN, VA / ACCESSWIRE / May 1, 2024 / Gladstone Capital Corporation (NASDAQ:GLAD) (the "Company") today announced earnings for its second fiscal quarter ended March 31, 2024. Please read the Company's... ► Artikel lesen
Mi	GLADSTONE CAPITAL CORP - 8-K, Current Report
Mi	GLADSTONE CAPITAL CORP - 10-Q, Quarterly Report

Zeit

Aktuelle Nachrichten

Earnings call: Gladstone Capital reports Q2 results, maintains dividend growth

Gladstone Capital declares $0.165 dividend

Gladstone Capital Corporation Reports Financial Results for Its Second Quarter Ended March 31, 2024

MCLEAN, VA / ACCESSWIRE / May 1, 2024 / Gladstone Capital Corporation (NASDAQ:GLAD) (the "Company") today announced earnings for its second fiscal quarter ended March 31, 2024. Please read the Company's...
► Artikel lesen

GLADSTONE CAPITAL CORP - 8-K, Current Report

GLADSTONE CAPITAL CORP - 10-Q, Quarterly Report

Zeit	Aktuelle Nachrichten
Do	Scope AI Corp.: SCOPE AI PROVIDES CORPORATE UPDATE	VANCOUVER, BC, May 2, 2024 /PRNewswire/ -- Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope" or the "Company") is pleased to provide an update on new developments of Scope's artificial... ► Artikel lesen
Mo	Scope AI Corp: Scope AI appoints Young as CEO
Mo	Scope AI Corp.: SCOPE AI PROVIDES CORPORATE UPDATE	VANCOUVER, BC, April 29, 2024 /PRNewswire/ -- Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope" or the "Company") is pleased to announce the appointment of James Young as Chief... ► Artikel lesen
05.04.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 05.04.2024	The following instruments on XETRA do have their first trading 05.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 05.04.2024 Aktien 1 CA58406U1012 MedBright AI Investments... ► Artikel lesen
04.04.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 04.04.2024	The following instruments on Boerse Frankfurt do have their last trading day on 04.04.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 04.04.2024ISIN NameAU000000MXC6 MGC... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Scope AI Corp.: SCOPE AI PROVIDES CORPORATE UPDATE

VANCOUVER, BC, May 2, 2024 /PRNewswire/ -- Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope" or the "Company") is pleased to provide an update on new developments of Scope's artificial...
► Artikel lesen

Scope AI Corp: Scope AI appoints Young as CEO

Scope AI Corp.: SCOPE AI PROVIDES CORPORATE UPDATE

VANCOUVER, BC, April 29, 2024 /PRNewswire/ -- Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope" or the "Company") is pleased to announce the appointment of James Young as Chief...
► Artikel lesen

05.04.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 05.04.2024

The following instruments on XETRA do have their first trading 05.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 05.04.2024 Aktien 1 CA58406U1012 MedBright AI Investments...
► Artikel lesen

04.04.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 04.04.2024

The following instruments on Boerse Frankfurt do have their last trading day on 04.04.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 04.04.2024ISIN NameAU000000MXC6 MGC...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
ARGENT BIOPHARMA LIMITED	0,210	-3,67 %
CARTESIAN THERAPEUTICS INC	23,050	+10,02 %
ENSURGE MICROPOWER ASA	0,123	+7,73 %
GLADSTONE CAPITAL CORPORATION	19,710	-0,40 %
SCOPE AI CORP	1,375	+2,23 %

Unternehmen / Aktien

Kurs

ARGENT BIOPHARMA LIMITED

0,210

-3,67 %

CARTESIAN THERAPEUTICS INC

23,050

+10,02 %

ENSURGE MICROPOWER ASA

0,123

+7,73 %

GLADSTONE CAPITAL CORPORATION